VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma

[1]  R. Mansel,et al.  PGF isoforms, PLGF-1 and PGF-2 and the PGF receptor, neuropilin, in human breast cancer: prognostic significance. , 2009, Oncology reports.

[2]  W. Jiang,et al.  PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance. , 2009, Cancer genomics & proteomics.

[3]  P. Carmeliet,et al.  “Antimyeloangiogenic” Therapy for Cancer by Inhibiting PlGF , 2009, Clinical Cancer Research.

[4]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[5]  Frederik De Smet,et al.  Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization , 2009, Cell.

[6]  Christian Fischer,et al.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.

[7]  Zhen-ping Zhu,et al.  VEGF signaling on hematopoietic precursors restricts B-lymphoid commitment in vitro and in vivo. , 2008, Experimental hematology.

[8]  D. Rades,et al.  Impact of VEGF and VEGF Receptor 1 (FLT1) Expression on the Prognosis of Stage III Esophageal Cancer Patients after Radiochemotherapy* , 2008, Strahlentherapie und Onkologie.

[9]  L. Ellis,et al.  VEGF-targeted therapy: mechanisms of anti-tumour activity , 2008, Nature Reviews Cancer.

[10]  Gabriele Bergers,et al.  Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.

[11]  Mélanie Schmidt,et al.  Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage. , 2008, Anticancer research.

[12]  Ruud H. Brakenhoff,et al.  Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.

[13]  Ines Gockel,et al.  Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer. , 2008, Oncology reports.

[14]  T. Dønnem,et al.  Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer , 2007, Clinical Cancer Research.

[15]  M. Giacca,et al.  Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels , 2007, Cell.

[16]  R. Jain,et al.  Down-Regulation of Placenta Growth Factor by Promoter Hypermethylation in Human Lung and Colon Carcinoma , 2007, Molecular Cancer Research.

[17]  C. Bokemeyer,et al.  Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis , 2007, Clinical Cancer Research.

[18]  A. Bikfalvi,et al.  Tumor angiogenesis , 2020, Advances in cancer research.

[19]  H. Tomita,et al.  Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma. , 2006, Oncology reports.

[20]  R. Figlin,et al.  Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Philipp Busch,et al.  Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. , 2005, Journal of the National Cancer Institute.

[22]  Jun Cai,et al.  Placenta growth factor is over-expressed and has prognostic value in human breast cancer. , 2005, European journal of cancer.

[23]  R. Mansel,et al.  Expression of Placenta growth factor (PlGF) in non-Small cell Lung cancer (NSCLC) and the clinical and prognostic significance , 2005, World journal of surgical oncology.

[24]  Oriol Casanovas,et al.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. , 2005, Cancer cell.

[25]  F. Hsieh,et al.  Placenta growth factor expression is correlated with survival of patients with colorectal cancer , 2005, Gut.

[26]  King-Jen Chang,et al.  The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. , 2004, Cancer letters.

[27]  Christoph Dehio,et al.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 , 2003, Nature Medicine.

[28]  T. H. van der Kwast,et al.  Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma , 2003, Journal of clinical pathology.

[29]  H. Kuwano,et al.  Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. , 2002, Anticancer research.

[30]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[31]  G. Steiner,et al.  Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. , 2000, The Journal of urology.

[32]  J. Vaillant,et al.  Vegf, vegf‐B, vegf‐C and their receptors KDR, FLT‐1 and FLT‐4 during the neoplastic progression of human colonic mucosa , 2000, International journal of cancer.

[33]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[34]  A. N. Corps,et al.  Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[35]  I. Takanami,et al.  Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. , 1997, Anticancer research.

[36]  K. Pantel,et al.  Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region. , 1995, International journal of oral and maxillofacial surgery.

[37]  A. Ullrich,et al.  Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. , 1993, Cancer research.